CRISPR 基因组治疗市场按产品类型、应用、最终用户和地区划分

2025 年 CRISPR 基因组治疗市场规模估计为 46.2 亿美元，预计到 2032 年将达到 170.4 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 20.5%。

全球 CRISPR 基因组治疗市场是全球生物技术产业中一个快速发展的领域。 CRISPR（成簇的规律间隔的短回文重复序列）是一种突破性的基因编辑技术，可对基因组 DNA 进行精确的定向改变。该技术有可能改变多种疾病的治疗方法，包括遗传疾病、癌症和感染疾病。 CRISPR 基因组治疗市场的发展受到遗传疾病日益普及的推动以及对有效治疗方法日益增长的需求的驱动。该技术能够以前所未有的精度修改基因，为治疗以前被认为无法治癒的疾病开闢了新的可能性。此外，CRISPR 技术的进步，例如开发更有效率、更安全的基因编辑工具，预计将进一步推动该市场的成长。对研发活动的投资不断增加以及生物技术公司和研究机构之间合作的不断加强也促进了全球 CRISPR 基因组治疗市场的扩张。然而，市场面临着许多挑战，包括与基因编辑相关的伦理和安全问题、监管障碍，以及开发和商业化基于 CRISPR 的治疗方法的高成本。儘管面临这些挑战，但全球 CRISPR 基因组治疗市场预计将在未来几年实现显着成长，这得归功于该技术在医疗保健领域带来的巨大变革潜力。总而言之，全球 CRISPR 基因组治疗市场是一个充满希望和活力的领域，有潜力为各种疾病的治疗带来重大进展。

市场动态：

慢性病、遗传疾病、感染疾病、神经系统疾病、血液疾病和代谢性疾病盛行率上升、老年人口增长、对安全有效治疗和疗法的需求增加、细胞和基因治疗资金增加、基因疗法的频繁核准、新疗法的引入以及人们对全球 CRISPR 基因组治疗市场的认识不断提高，是预计在预测期内促进全球 CRISPR 基因组治疗市场增长的关键因素。

例如，2021年3月，来自加州大学旧金山分校、加州大学柏克莱分校和加州大学洛杉矶分校（UCLA）的科学家获得美国食品药物管理局（FDA）的核准，共同启动一项针对镰状细胞病患者的CRISPR基因校正疗法的早期、首次人体临床试验，该疗法将使用患者自身的造血干细胞进行治疗。与目前从健康骨髓捐赠者进行干细胞移植的治疗方法相比，该治疗方法可以创造一种更安全、更便捷且可能治癒镰状细胞疾病的治疗治疗方法，从而彻底改变镰状状细胞疾病的治疗方式。此外，该治疗方法还可以预防镰状细胞疾病不可逆的併发症。

本研究的主要特点

• 本报告对全球 CRISPR 基因组治疗市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和復合年增长率。
• 它还揭示了各个领域的潜在商机，并解释了该市场的引人注目的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 全球 CRISPR 基因组治疗市场的主要企业会根据以下参数进行分析，例如公司亮点、产品系列、关键亮点、财务表现和策略。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球 CRISPR 基因组治疗市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员将透过用于分析全球 CRISPR 基因组治疗市场的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景

4. 全球 CRISPR 基因组治疗市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020 年至 2032 年全球 CRISPR 基因组治疗市场（依产品类型）

• 套件和试剂
• 图书馆
• 向量设计
• 试验设计
• 其他的

6. 全球 CRISPR 基因组治疗市场（按应用划分），2020 年至 2032 年

• 肿瘤学
• 遗传性疾病
• 基因组工程
• 其他的

7. 2020 年至 2032 年全球 CRISPR 基因组治疗市场（依最终使用者划分）

• 生物製药公司
• 受託研究机构（CRO）
• 基因研究
• 其他的

8. 全球 CRISPR 基因组治疗市场（按地区），2020 年至 2032 年

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 印度
  • 中国
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲国家
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第九章 竞争态势

• Merck KgaA
• Thermo Fisher Scientific Inc.
• Origene Technologies, Inc.
• New England Biolabs
• Intellia Therapeutics, Inc.
• GenScript
• GeneCopoeia, Inc.
• Cellectis
• Mammoth Biosciences
• Precision Biosciences, Inc.
• Synthego Corporation
• CRISPR Therapeutics
• Horizon Discovery Group plc
• Lonza Group Ltd.
• Takara Bio Inc.

第 10 章 章节

• 调查方法
• 关于出版商

CRISPR Genomic Cure Market is estimated to be valued at USD 4.62 Bn in 2025 and is expected to reach USD 17.04 Bn by 2032, growing at a compound annual growth rate (CAGR) of 20.5% from 2025 to 2032.

The global CRISPR genomic cure market is a rapidly evolving sector within the global biotechnology industry. CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. This technology has the potential to transform the treatment of a wide range of diseases, including genetic disorders, cancers, and infectious diseases. The market for CRISPR genomic cures is driven by the increasing prevalence of genetic diseases and the growing demand for effective therapies. The technology's ability to modify genes with unprecedented precision has opened up new possibilities for the treatment of diseases that were previously considered untreatable. Moreover, advancements in CRISPR technology, such as the development of more efficient and safer gene-editing tools, are expected to further propel the growth of this market. The increasing investment in research and development activities, coupled with the growing collaboration between biotechnology companies and research institutes, is also contributing to the expansion of the global CRISPR genomic cure market. However, the market faces several challenges, including ethical and safety concerns related to gene editing, regulatory hurdles, and the high cost of developing and commercializing CRISPR-based therapies. Despite these challenges, the global CRISPR genomic cure market is expected to witness significant growth in the coming years, driven by the technology's immense potential to revolutionize healthcare. In conclusion, the global CRISPR genomic cure market represents a promising and dynamic field with the potential to bring about significant advancements in the treatment of various diseases.

Market Dynamics:

Increasing prevalence of chronic disease, genetic disease, infectious diseases, neurological disease, blood disease, and metabolic disease, a growing geriatric population, growing demand for safe and effective treatment or therapies, increasing funding for cell and gene therapies, frequent approvals for gene therapies, the introduction of novel therapies, and increasing awareness among people about the global CRISPR genomic cure market are major factors expected to augment the growth of the global CRISPR genomic cure market during the forecast period.

For instance, in March 2021, scientists at UC San Francisco, UC Berkeley, and UCLA received U.S. Food and Drug Administration (FDA) approval to jointly launch an early-phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells. The therapy has the potential to transform sickle cell disease care by producing an accessible, curative treatment that is safer than the current therapy of stem cell transplant from a healthy bone marrow donor. Moreover, the therapy has the potential to prevent irreversible complications of the disease.

Key features of the study:

• This report provides in-depth analysis of the global CRISPR genomic cure market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global CRISPR genomic cure market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., Origene Technologies, Inc., New England Biolabs, Intellia Therapeutics, Inc., GenScript, GeneCopoeia, Inc., Cellectis, Mammoth Biosciences, Precision Biosciences, Inc., Synthego Corporation, CRISPR Therapeutics, Horizon Discovery Group plc, Lonza Group Ltd., Takara Bio Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global CRISPR genomic cure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CRISPR genomic cure market

Detailed Segmentation:

• By Product Type:
  • Kits & Reagents
  • Libraries
  • Vector Design
  • Assay Design
  • Others
• By Application:
  • Oncology
  • Genetic Diseases
  • Genomic Engineering
  • Others
• By End User:
  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Genetic Research Laboratories
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Origene Technologies, Inc.
  • New England Biolabs
  • Intellia Therapeutics, Inc.
  • GenScript
  • GeneCopoeia, Inc.
  • Cellectis
  • Mammoth Biosciences
  • Precision Biosciences, Inc.
  • Synthego Corporation
  • CRISPR Therapeutics
  • Horizon Discovery Group plc
  • Lonza Group Ltd.
  • Takara Bio Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • CRISPR Genomic Cure Market, By Product Type
  • CRISPR Genomic Cure Market, By Application
  • CRISPR Genomic Cure Market, By End User
  • CRISPR Genomic Cure Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global CRISPR Genomic Cure Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global CRISPR Genomic Cure Market, By Product Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Kits & Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Libraries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Vector Design
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Assay Design
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global CRISPR Genomic Cure Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Genetic Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Genomic Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global CRISPR Genomic Cure Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Genetic Research Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global CRISPR Genomic Cure Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • India
    • China
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of the APAC
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Merck KgaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Origene Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• New England Biolabs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Intellia Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GenScript
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GeneCopoeia, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cellectis
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mammoth Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Precision Biosciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Synthego Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CRISPR Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Horizon Discovery Group plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lonza Group Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takara Bio Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us